ArticleEJHaem2026

Efficacy and Safety of Azacitidine Combined With Lisaftoclax in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome With Increased Blasts.

Shan Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.